Policy changes Backwork has recorded, newest first. The most recent change on record is from October 11, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
82,244 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Pasireotide (e.g., Signifor or Signifor LAR) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Panitumumab (e.g., Vectibix) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Paliperidone Palmitate (e.g., Long-acting Injectables Invega Sustenna & Invega Trinza, Erzofri) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Olipudase alfa (e.g., Xenpozyme) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Octreotide Acetate (e.g., Sandostatin) for Injectable Suspension (e.g., Sandostatin LAR Depot) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Ocrelizumab (e.g., Ocrevus) and Ocrelizumab with Hyaluronidase (e.g., Ocrevus Zunovo) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Obinutuzumab (e.g., Gazyva) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Non-Bevacizumab Vascular Epithelial Growth Factors for Ophthalmic Use (e.g., Beovu, Byooviz, Cimerli, Eylea, Eylea HD, Lucentis, Pavblu, Vabysmo, Enzeevu, Ahzantive, Yesafili, Opuviz) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Nogapendekin alfa inbakicept-pmln (e.g., Anktiva) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Nivolumab and relatlimab-rmbw (e.g., Opdualag) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Nivolumab and Hyaluronidase (e.g., Opdivo Qvantig) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Nivolumab (e.g., Opdivo) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Nipocalimab (e.g., Imaavy) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Naxitamab-gqgk (e.g., Danyelza) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Natalizumab (e.g., Tysabri) and Biosimilars | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Nadofaragene firadenovec-vncg (e.g., Adstiladrin) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Nab-Paclitaxel (e.g., Abraxane) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Mosunetuzumab-axgb (e.g. Lunsumio and Lunsumio Velo) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Monoclonal Antibodies for Treatment of Alzheimer Disease [Aducanumab (e.g., Aduhelm) and Lecanemab (e.g., Leqembi)] | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Mogamulizumab- kpkc (e.g., Poteligeo) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Mitomycin Intravesical Solution (e.g., Zusduri) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Mitomycin Gel (e.g., Jelmyto) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Mirvetuximab soravtansine-gynx (e.g. Elahere) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Measurement of Serum Antibodies to Infliximab, Adalimumab, Vedolizumab, and Ustekinumab | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Margetuximab-cmkb (e.g., Margenza) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Luspatercept-aamt (e.g., Reblozyl) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Lurbinectedin (e.g., Zepzelca) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Lumasiran (e.g., Oxlumo) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Loncastuximab tesirine-lpyl (e.g., Zynlonta) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Lisocabtagene Maraleucel (e.g., Breyanzi) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Linvoseltamab-gcpt (e.g., Lynozyfic) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Levoleucovorin Calcium (e.g., Khapzory) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Leuprolide Acetate (e.g., Lupron Depot; Fensolvi) for Non-Oncologic Indications | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Lenacapavir (e.g., Sunlenca) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Lanreotide (e.g., Lanreotide injection, Somatuline depot) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Isatuximab-irfc (e.g., Sarclisa) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Irinotecan Liposomal (e.g., Onivyde) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Ipilimumab (e.g., Yervoy) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Intravitreal, Punctum Corticosteroid Implants (e.g., Retisert, Yutiq, Iluvien, Ozurdex, and Dextenza) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Inotuzumab Ozogamicin (e.g., Besponsa) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Infliximab (e.g., Remicade and Unbranded Infliximab) and Biosimilars | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Inebilizumab-cdon (e.g., Uplizna) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Inclisiran (e.g., Leqvio) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Imetelstat (e.g., Rytelo) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Idecabtagene Vicleucel (e.g., Abecma) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Guselkumab (e.g., Tremfya ) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Golimumab (e.g., Simponi Aria) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Glofitamab-gxbm (e.g., Columvi) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Givosiran (e.g., GIVLAARI) | Codes changed |
| Aug 22, 2026 | Arkansas Blue Cross and Blue Shield | Genetic Test: Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients with Cancer | Codes changed |